140 related articles for article (PubMed ID: 21083481)
1. Dried blood spot sampling for quantitative bioanalysis: time for a revolution?
Spooner N
Bioanalysis; 2010 Nov; 2(11):1781. PubMed ID: 21083481
[No Abstract] [Full Text] [Related]
2. A glowing future for dried blood spot sampling.
Spooner N
Bioanalysis; 2010 Aug; 2(8):1343-4. PubMed ID: 21083330
[No Abstract] [Full Text] [Related]
3. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs.
Denniff P; Spooner N
Bioanalysis; 2010 Aug; 2(8):1385-95. PubMed ID: 21083339
[TBL] [Abstract][Full Text] [Related]
4. Increasing efficiency for dried blood spot analysis: prospects for automation and simplified sample analysis.
Wong P; Pham R; Bruenner BA; James CA
Bioanalysis; 2010 Nov; 2(11):1787-9. PubMed ID: 21083483
[No Abstract] [Full Text] [Related]
5. Validation of individual quantitative methods for determination of cytochrome P450 probe substrates in human dried blood spots with HPLC-MS/MS.
Lad R
Bioanalysis; 2010 Nov; 2(11):1849-61. PubMed ID: 21083493
[TBL] [Abstract][Full Text] [Related]
6. A powerful couple in the future of clinical biochemistry: in situ analysis of dried blood spots by ambient mass spectrometry.
Corso G; D'Apolito O; Gelzo M; Paglia G; Dello Russo A
Bioanalysis; 2010 Nov; 2(11):1883-91. PubMed ID: 21083496
[TBL] [Abstract][Full Text] [Related]
7. Effect of storage conditions on the weight and appearance of dried blood spot samples on various cellulose-based substrates.
Denniff P; Spooner N
Bioanalysis; 2010 Nov; 2(11):1817-22. PubMed ID: 21083489
[TBL] [Abstract][Full Text] [Related]
8. Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations.
Spooner N; Ramakrishnan Y; Barfield M; Dewit O; Miller S
Bioanalysis; 2010 Aug; 2(8):1515-22. PubMed ID: 21083351
[TBL] [Abstract][Full Text] [Related]
9. Utilization of dried blood spots within drug discovery: modification of a standard DiLab(®) AccuSampler(®) to facilitate automatic dried blood spot sampling.
Clark GT; Giddens G; Burrows L; Strand C
Lab Anim; 2011 Apr; 45(2):124-6. PubMed ID: 21355022
[TBL] [Abstract][Full Text] [Related]
10. Utility of dried blood spot sampling and storage for increased stability of photosensitive compounds.
Bowen CL; Hemberger MD; Kehler JR; Evans CA
Bioanalysis; 2010 Nov; 2(11):1823-8. PubMed ID: 21083490
[TBL] [Abstract][Full Text] [Related]
11. Study to assess the effect of age of control human and animal blood on its suitability for use in quantitative bioanalytical DBS methods.
Abu-Rabie P; Spooner N
Bioanalysis; 2010 Aug; 2(8):1373-84. PubMed ID: 21083338
[TBL] [Abstract][Full Text] [Related]
12. Determination of naproxen using DBS: evaluation & pharmacokinetic comparison of human plasma versus human blood DBS.
Youhnovski N; Michon J; Latour S; Mess JN; Bergeron A; Furtado M; Rufiange M; Guibord P; Lefebvre M; Macarthur RB; Garofolo F
Bioanalysis; 2010 Aug; 2(8):1501-13. PubMed ID: 21083350
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic considerations as to when to use dried blood spot sampling.
Emmons G; Rowland M
Bioanalysis; 2010 Nov; 2(11):1791-6. PubMed ID: 21083484
[TBL] [Abstract][Full Text] [Related]
14. European Bioanalysis Forum continued plans to support liquid microsampling.
Timmerman P; White S; Cobb Z; Woods K; de Vries R; Spooner N; Sangster T; Dillen L; Hawthorne G
Bioanalysis; 2014; 6(14):1897-900. PubMed ID: 25158961
[No Abstract] [Full Text] [Related]
15. Validation of a high-sensitivity assay for zatebradine in dried blood spots of human blood at pg/ml concentrations using HILIC-MS/MS.
Michi M; Ferrari L
Bioanalysis; 2010 Nov; 2(11):1863-71. PubMed ID: 21083494
[TBL] [Abstract][Full Text] [Related]
16. EBF: reflection on bioanalytical assay requirements used to support liquid microsampling.
White S; Hawthorne G; Dillen L; Spooner N; Woods K; Sangster T; Cobb Z; Timmerman P
Bioanalysis; 2014; 6(19):2581-6. PubMed ID: 25411700
[No Abstract] [Full Text] [Related]
17. GlaxoSmithKline's experience of incurred sample reanalysis for dried blood spot samples.
Barfield M; Ahmad S; Busz M
Bioanalysis; 2011 May; 3(9):1025-30. PubMed ID: 21545350
[TBL] [Abstract][Full Text] [Related]
18. Sensitive determination of a drug candidate in dried blood spots using a TLC-MS interface integrated into a column-switching LC-MS/MS system.
Heinig K; Wirz T; Gajate-Perez A
Bioanalysis; 2010 Nov; 2(11):1873-82. PubMed ID: 21083495
[TBL] [Abstract][Full Text] [Related]
19. Application of the DBS methodology to a toxicokinetic study in rats and transferability of analysis between bioanalytical laboratories.
Turpin PE; Burnett JE; Goodwin L; Foster A; Barfield M
Bioanalysis; 2010 Aug; 2(8):1489-99. PubMed ID: 21083349
[TBL] [Abstract][Full Text] [Related]
20. The application of dried blood spot sampling in global clinical trials.
Amsterdam Pv; Waldrop C
Bioanalysis; 2010 Nov; 2(11):1783-6. PubMed ID: 21083482
[No Abstract] [Full Text] [Related]
[Next] [New Search]